Yoshiyuki Suzuki

发表

Pd-ECGF positivity correlates with better survival, while iNOS has no predictive value for cervical carcinomas treated with radiotherapy.

Takashi Nakano, Yoshiyuki Suzuki, T. Nakano, 2003, International journal of radiation oncology, biology, physics.

False-positive results obtained from the branch-site test of positive selection.

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2008, Genes & genetic systems.

N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease

Seiichiro Ogawa, Yuji Matsuzaki, Akira Oka, 2004 .

Molecular form and subcellular distribution of acid β-galactosidase in fibroblasts from patients with GM1 gangliosidosis, Morquio B disease and galactosialidosis

Hitoshi Sakuraba, Yoshiyuki Suzuki, H. Sakuraba, 1997, Brain and Development.

Overcredibility of molecular phylogenies obtained by Bayesian phylogenetics

Masatoshi Nei, G. Glazko, M. Nei, 2002, Proceedings of the National Academy of Sciences of the United States of America.

The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.

Alona Muzikansky, Arnab Chakravarti, Peter M Black, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reliabilities of identifying positive selection by the branch-site and the site-prediction methods

Masatoshi Nei, M. Nei, Yoshiyuki Suzuki, 2009, Proceedings of the National Academy of Sciences.

Therapeutic chaperone effect of N-octyl 4-epi-β-valienamine on murine G(M1)-gangliosidosis.

Takatoshi Kubo, Seiichiro Ogawa, Katsumi Higaki, 2012, Molecular genetics and metabolism.

Spatial resolution of multi-head Si/CdTe Compton camera for medical application

Shin Watanabe, Naoki Kawachi, Shin-nosuke Ishikawa, 2009, 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC).

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options.

Kenji Ikeda, Hiroki Ishikawa, Kazuaki Chayama, 2013, Journal of hepatology.

Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor

Satoshi Ishii, Yoshiyuki Suzuki, S. Ishii, 1999, Nature Medicine.

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy

Hiro Sato, Yoshiyuki Suzuki, J. Saitoh, 2015, Cureus.

Protective Protein as an Endogenous Endothelin Degradation Enzyme in Human Tissues (*)

Hitoshi Sakuraba, Yoshiyuki Suzuki, H. Sakuraba, 1995, The Journal of Biological Chemistry.

New Methods for Detecting Positive Selection at Single Amino Acid Sites

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2004, Journal of Molecular Evolution.

CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinoma.

Hideyuki Sakurai, Hitoshi Ishikawa, Takashi Nakano, 2004, Brachytherapy.

Compensatory Evolution of Net-Charge in Influenza A Virus Hemagglutinin

Yoshiyuki Suzuki, Y. Kobayashi, Yoshiyuki Suzuki, 2012, PloS one.

Chemical chaperone therapy for brain pathology in GM1-gangliosidosis

Seiichiro Ogawa, Yoshimi Ogawa, Yuji Matsuzaki, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Galactose stabilizes various missense mutants of α-galactosidase in Fabry disease

Satoshi Ishii, Toshihiro Takenaka, Hitoshi Sakuraba, 1995 .

Transcriptional Interferences in cis Natural Antisense Transcripts of Humans and Mice

Kazuho Ikeo, Takashi Gojobori, Naoki Osato, 2007, Genetics.

Three-dimensional window analysis for detecting positive selection at structural regions of proteins.

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2004, Molecular biology and evolution.

Detection of positive selection eliminating effects of structural constraints in hemagglutinin of H3N2 human influenza A virus.

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Natural selection on the influenza virus genome.

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2006, Molecular biology and evolution.

Origin and evolution of influenza virus hemagglutinin genes.

Masatoshi Nei, M. Nei, Yoshiyuki Suzuki, 2002, Molecular biology and evolution.

Inferring natural selection operating on conservative and radical substitution at single amino acid sites.

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2007, Genes & genetic systems.

Estimation of energy range measurements with newly developed Si/CdTe Compton camera for nuclear medicine imaging

Motohide Kokubun, Tomihiro Kamiya, Hirokazu Odaka, 2010, IEEE Nuclear Science Symposuim & Medical Imaging Conference.

The neutral theory of molecular evolution in the genomic era.

Masatoshi Nei, M. Nei, Yoshiyuki Suzuki, 2010, Annual review of genomics and human genetics.

Molecular basis of chemical chaperone effects of N-octyl-β-valienamine on human β-glucosidase in low/neutral pH conditions

Seiichiro Ogawa, Yasubumi Sakakibara, Katsuyuki Yugi, 2010 .

Candidate molecules for chemical chaperone therapy of GM1-gangliosidosis.

Katsumi Higaki, Yoshiyuki Suzuki, K. Higaki, 2013, Future medicinal chemistry.

Chemical modification of the β-glucocerebrosidase inhibitor N-octyl-β-valienamine : synthesis and biological evaluation of 4-epimeric and 4-O-(β-D-galactopyranosyl) derivatives

Seiichiro Ogawa, Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2002 .

β-Galactosidase deficiency: An approach to chaperone therapy

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2006, Journal of Inherited Metabolic Disease.

Simulation study of the reliability and robustness of the statistical methods for detecting positive selection at single amino acid sites.

Masatoshi Nei, M. Nei, Yoshiyuki Suzuki, 2002, Molecular biology and evolution.

Imaging of 99mTc-DMSA and 18F-FDG in humans using a Si/CdTe Compton camera

Tomihiro Kamiya, Hirokazu Odaka, Shin Watanabe, 2020, Physics in medicine and biology.

Chaperone Therapy for Neuronopathic Lysosomal Diseases: Competitive Inhibitors as Chemical Chaperones for Enhancement of Mutant Enzyme Activities

Seiichiro Ogawa, Yasubumi Sakakibara, Y. Sakakibara, 2009, Perspectives in medicinal chemistry.

False-positive selection identified by ML-based methods: examples from the Sig1 gene of the diatom Thalassiosira weissflogii and the tax gene of a human T-cell lymphotropic virus.

Masatoshi Nei, M. Nei, Yoshiyuki Suzuki, 2004, Molecular biology and evolution.

Randomized Controlled Trial Comparing the Efficacy of Impedance Control and Temperature Control of Radiofrequency Interstitial Thermal Ablation for Treating Small Hepatocellular Carcinoma

Kenji Ikeda, Tetsuya Hosaka, Masahiro Kobayashi, 2015, Oncology.

A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.

Kei Yura, Yasubumi Sakakibara, Katsumi Higaki, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study

Tatsuya Ohno, Takashi Nakano, Yoshiyuki Suzuki, 2012, Journal of radiation research.

Differential evolutionary rates of duplicated genes in protein interaction network.

Takashi Makino, Takashi Gojobori, T. Gojobori, 2006, Gene.

Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinoma

Kenji Ikeda, Tetsuya Hosaka, Miharu Hirakawa, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

A phylogenetic approach to detecting reassortments in viruses with segmented genomes.

Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2010, Gene.

Chemical modification of the beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of 4-epimeric and 4-O-(beta-D-galactopyranosyl) derivatives.

Seiichiro Ogawa, Yoshiyuki Suzuki, Yoshiyuki Suzuki, 2002, Bioorganic & medicinal chemistry.